About this Research Topic
As sarcopenic obesity is associated with multiple adverse health outcomes, its treatment should be taken into consideration. Lifestyle modification, including dietary intervention and physical exercise, is the cornerstone of sarcopenic obesity treatment. The aims of sarcopenic obesity treatment are fat mass loss, together with muscle mass preservation and physical function improvement.
Through this Research Topic we aim:
• To identify the best diagnostic tool for sarcopenic obesity in clinical practice
• To assist establishing the diagnostic criteria for sarcopenic obesity
• To investigate the best treatment strategies for sarcopenic obesity
• To improve patient outcome and reduce the burden of disease
We encourage researchers from different scientific backgrounds to submit to this Research Topic entitled "New insights in Sarcopenic Obesity Diagnostic Criteria and Treatment: a Call for Action” that will accept manuscripts in the form of Original Research, Systematic Review (and meta-analysis), Narrative Review, Mini-Review, and Clinical Trial articles to provide a platform for the presentation of recent advances in the knowledge on sarcopenic obesity. Ultimately, we aim to provide a deeper understanding and emphasis on the crucial aspects of this condition in order to avoid bias and misinterpretations and improve patient outcomes.
In brief, there are three important clinical questions (but not limited to) that need to be addressed are:
• What is the best diagnostic tool for sarcopenic obesity in clinical practice?
• What are the best diagnostic criteria of sarcopenic obesity?
• What are the best treatment strategies for sarcopenic obesity?
Keywords: Sarcopenia, lifestyle, obesity, elderly
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.